Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | +3.12% | +3.94% | +12.82% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.82% | 98.65M | |
+7.52% | 113B | |
+11.38% | 106B | |
+0.99% | 22.27B | |
-12.64% | 22.22B | |
-5.52% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Clearside Biomedical Stock